FDA Considers 'Women's Viagra.' Again.04:52
Download

Play
In this  Friday, Sept. 27, 2013, photo, Cindy Whitehead holds a tablet of flibanserin in her office at Sprout Pharmaceuticals in Raleigh, N.C. (Allen G. Breed/AP)
In this Friday, Sept. 27, 2013, photo, Cindy Whitehead holds a tablet of flibanserin in her office at Sprout Pharmaceuticals in Raleigh, N.C. (Allen G. Breed/AP)
This article is more than 4 years old.

Food and Drug Administration advisers are meeting today to consider — again — whether to recommend the first-ever pill that would increase sexual desire in women. The drug, flibanserin, has already been rejected twice by the FDA.

Some women's groups — including one backed by the drug's developer — are accusing the FDA of gender bias, for approving drugs that treat sexual dysfunction in men, but not in women. The FDA rejects that claim.

Here & Now's Robin Young talks to Emily Nagoski, the director of wellness education at Smith College and the author of "Come As You Are: The Surprising New Science That Will Transform Your Sex Life," about the debate over the pill.

Guest

  • Emily Nagoski is the director of wellness education at Smith College and the author of "Come As You Are: The Surprising New Science That Will Transform Your Sex Life."

This segment aired on June 4, 2015.

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news